Primary Site >> Stomach Cancer
Gene >> ERCC2
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy. PMID: 17009404 |
Ref: Identification of novel gastric cancer-associated CNVs by integrated analysis of microarray. PMID: 20872948 |
Ref: The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis. PMID: 23028453 |
Ref: XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies. PMID: 23534729 Ref: A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population. PMID: 23680703 Ref: ERCC1 and ERCC2 variants predict survival in gastric cancer patients. PMID: 24023723 |
Ref: Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer. PMID: 25542228 Ref: Genetic variability of DNA repair mechanisms influences chemotherapy outcome of gastric cancer. PMID: 26097599 Ref: Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer. PMID: 26191265 Ref: Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction. PMID: 26499900 Ref: Genetic variability of DNA repair mechanisms influences treatment outcome of gastric cancer. PMID: 26622786 Ref: Genetic variability of DNA repair mechanisms in chemotherapy treatment outcome of gastric cancer patients. PMID: 26681216 Ref: Genetic variability of ERCC1 and ERCC2 influences treatment outcomes in gastric cancer. PMID: 26782397 Ref: Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy. PMID: 26823845 |
Ref: Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy. PMID: 26314858 Ref: Genetic variability of ERCC1 and ERCC2 genes involved in the nucleotide excision repair pathway influences the treatment outcome of gastric cancer. PMID: 27173253 Ref: Polymorphisms of multiple genes involved in NER pathway predict prognosis of gastric cancer. PMID: 27340861 |
Ref: Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies. PMID: 27995989 Ref: Association between the ERCC2 Asp312Asn polymorphism and risk of cancer. PMID: 28489582 |
Ref: Genetic variants in the nucleotide excision repair pathway genes and gastric cancer susceptibility in a southern Chinese population. PMID: 29695933 |